Connecting you to content on EBSCOhost

Works by Pellet, Pascale

Results: 4

1

Efficacy and Safety of Subcutaneous Secukinumab 150 mg with or Without Loading Regimen in Psoriatic Arthritis: Results from the FUTURE 4 Study.

Published in:

Rheumatology & Therapy, 2019, v. 6, n. 3, p. 393, doi. 10.1007/s40744-019-0163-5

By:

Kivitz, Alan J.;
Nash, Peter;
Tahir, Hasan;
Everding, Andrea;
Mann, Heřman;
Kaszuba, Andrzej;
Pellet, Pascale;
Widmer, Albert;
Pricop, Luminita;
Abrams, Ken

Publication type:

Article

2

Alpha heavy chain disease of patient MAL: structure of the non-functional rearranged α gene translocated on chromosome 9.

Published in:

European Journal of Immunology, 1990, v. 20, n. 12, p. 2731, doi. 10.1002/eji.1830201230

By:

Pellet, Pascale;
Tsapis, Andreas;
Brouet, Jean-Claude

Publication type:

Article

3

Secukinumab Provides Sustained Improvements in the Signs and Symptoms of Psoriatic Arthritis: Final 5‐year Results from the Phase 3 FUTURE 1 Study.

Published in:

ACR Open Rheumatology, 2020, v. 2, n. 1, p. 18, doi. 10.1002/acr2.11097

By:

Mease, Philip J.;
Kavanaugh, Arthur;
Reimold, Andreas;
Tahir, Hasan;
Rech, Juergen;
Hall, Stephen;
Geusens, Piet;
Pellet, Pascale;
Delicha, Eumorphia Maria;
Pricop, Luminita;
Mpofu, Shephard

Publication type:

Article

4

258 Secukinumab provides sustained improvements in the signs and symptoms in psoriatic arthritis: final 5-year efficacy and safety results from the FUTURE 1 Phase 3 trial.

Published in:

2019

By:

Tahir, Hasan;
Mease, Philip J;
Kavanaugh, Arthur;
Reimold, Andreas;
Rech, Jürgen;
Hall, Stephen;
Geusens, Piet;
Pellet, Pascale;
Delicha, Eumorphia Maria;
Pricop, Luminita;
Mpofu, Shephard

Publication type:

Abstract